UK small-cap RNS · 16 Oct 2025
The key announcements of UK small & mid caps under £2bn on 16 Oct 2025 – situations they move are marked, with the share price since.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus director dealings and holdings that are part of a situation. Not investment advice.
| Date | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 16 Oct | React Group REAT | £9.5m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | TheraCryf Plc TCF | £3.8m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Vistry Group VTY | £806m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Vanquis Banking Group 20 VANQ | £181m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Dr. Martens DOCS | £628m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | YouGov YOU | £314m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Mountview Estates MTVW | £333m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Mortgage Advice Bureau (Holdings) MAB1 | £220m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Mortgage Advice Bureau (Holdings) MAB1 | £220m | Director dealing | Grant of Options, PDMR Dealing,Total Voting Rights | |
| 16 Oct | C&C Group (CDI) CCR | £383m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Cavendish Financial CAV | £23m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Grainger GRI | £1,340m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Cohort CHRT | £594m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Oxford Biomedica OXB | £622m | Director dealing | Director/PDMR Shareholding | |
| 16 Oct | Franchise Brands FRAN | £289m | Director dealing | Directors’ dealings
Franchise Brands plc (AIM: FRAN), an international multi-brand franchise business, announces that on 15 October 2025 Nigel Wray, a Non-executive director of the Company, bought 50,000 Ordinary Shares in the Company, at a price of 120.0 pence per share. |